Zobrazeno 1 - 10
of 437
pro vyhledávání: ''
Autor:
S. Erbel-Khurtsidze, I. Tudorache, Raphael Romano Bruno, Payam Akhyari, Udo Boeken, Hannan Dalyanoglu, Moritz Benjamin Immohr, Ralf Westenfeld, Hug Aubin, Artur Lichtenberg
Publikováno v:
Interactive CardioVascular and Thoracic Surgery. 34:462-469
OBJECTIVES Heart transplantation after left ventricular assist device (LVAD) implantation remains challenging. It is still unclear whether its support duration impacts the outcome after transplantation. METHODS All patients undergoing heart transplan
Autor:
Veronica Toro Arana, Kiah M. Williams, Y. Joseph Woo, Philip E. Oyer, Bharathi Lingala, Michael Baiocchi, Yasuhiro Shudo, Yuanjia Zhu
Publikováno v:
European Heart Journal. 42:4934-4943
Aims Since 1968, heart transplantation has become the definitive treatment for patients with end-stage heart failure. We aimed to summarize our experience in heart transplantation at Stanford University since the first transplantation performed over
Autor:
Darrell Loeffler, Michel T. Corban, Lilach O. Lerman, Ilke Ozcan, Takumi Toya, Ali Ahmad, Amir Lerman, David Morse, Sudhir S. Kushwaha
Publikováno v:
Cardiovascular Research. 118:1703-1712
Aims Circulating progenitor cells (CPCs) play a role in vascular repair and plaque stability, while osteocalcin (OC) expressing CPCs have been linked to unstable plaque and adverse cardiovascular outcomes. However, their role in cardiac allograft vas
Autor:
María J. Ruiz-Cano, Renné Schramm, Jan Gummert, Sebastian V. Rojas, Lylit Ramazyan, Michiel Morshuis, Volker Lauenroth, Lech Paluszkiewicz
Publikováno v:
European Journal of Cardio-Thoracic Surgery. 60:177-185
OBJECTIVES The development of late-onset right ventricular failure (LoRVF) that occurs months after a continuous-flow left ventricular assist device (LVAD) is implanted is a clinical problem that warrants investigation. Our goal was to study the inci
Publikováno v:
Clinical Kidney Journal
Background Users of guideline-recommended renin–angiotensin–aldosterone system (RAAS) inhibitors may experience disruptions to their treatment, e.g. due to hyperkalaemia, hypotension or acute kidney injury. The risks associated with treatment dis
Autor:
Nehal A. Sheth, Bonnie L. Blazer-Yost, Susan M. Perkins, Bradley J. Erickson, Kristen Ponsler-Sipes, Robert L. Bacallao, Kim Swinney, Marie E. Edwards, Ranjani N. Moorthi, Vicente E. Torres, Sharon M. Moe, Michelle LaPradd
Publikováno v:
Clinical Kidney Journal
Background Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common monogenetic disorders in humans and is characterized by numerous fluid-filled cysts that grow slowly, resulting in end-stage renal disease in the majority of pa
Publikováno v:
Nephrology Dialysis Transplantation. 37:681-686
Background Vitamin K antagonists (VKAs) are still in use for oral anticoagulation, but not all indications allow their replacement by direct oral anticoagulants. Although formal dose reduction is not required in patients with impaired kidney function
Autor:
Mei-Chuan Kuo, Shang-Jyh Hwang, Yi-Chun Tsai, Juan Jesus Carrero, Ping-Hsun Wu, Yi-Ting Lin, Yi-Wen Chiu, Jia-Sin Liu
Publikováno v:
Clinical Kidney Journal
Background Despite widespread use, there is no trial evidence to inform β-blocker’s (BB) relative safety and efficacy among patients undergoing hemodialysis (HD). We herein compare health outcomes associated with carvedilol or bisoprolol use, the
Autor:
Lawrence J. Appel, Pandu Rao, James P. Lash, Debbie L. Cohen, Sarah J. Schrauben, Clarissa J. Diamantidis, Sylvia E. Rosas, Chi-yuan Hsu, Aditya Surapaneni, Julia J. Scialla, Cric Study Investigators, James H. Sondheimer, Sankar D. Navaneethan, Jesse Y. Hsu, Jeffrey C. Fink, Morgan E. Grams, Dawei Xie, Alfred K. Cheung, Bernard G. Jaar, Harold I. Feldman
Publikováno v:
Nephrology Dialysis Transplantation. 36:1685-1693
Background Patients with chronic kidney disease (CKD) face risks of not only end-stage kidney disease (ESKD), cardiovascular disease (CVD) and death, but also decline in kidney function, quality of life (QOL) and mental and physical well-being. This
Autor:
Mario Cozzolino, Paola Ciceri
Publikováno v:
Clinical Kidney Journal
Iron deficiency is a frequent comorbidity of cardiovascular (CV) diseases and nearly 50% of patients with heart failure (HF) with or without anaemia have low levels of available iron. There is a strong association between anaemia and the increase in